P R Pharma Source Private Limited, a active private limited company, was established on 16 June 2007 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52311MH2007PTC171721. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Paresh Shantilal Bagadia (Managing Director), Kaushik Mahendra Mehta (Additional Director). Past directors included Paresh Shantilal Bagadia, Aditya Gupta, Tejas Champaklal Shah. It holds no open charges and ₹1.80 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-407, Anjani Complex, Opp. Gurunanak Petrol Pump, Chakala, Andheri East,, Mumbai, Maharashtra, 400099.
U52311MH2007PTC171721
171721
16 June 2007
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into P R Pharma Source Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paresh Shantilal Bagadia | Managing Director | 16 Jun 2007 | Current |
| Kaushik Mahendra Mehta | Additional Director | 06 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jul 2013 | Past |
| Pramod Abcsdd | Director | 20 Jan 2015 | Past |
| Pramod Abcsdd | Director | 28 Feb 2014 | Past |
| Pramod Abcsdd | Additional Director | 05 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
P R Pharma Source Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 10.86% decrease. The company also saw a slight decrease in profitability, with a 6.58% decrease in profit. The company's net worth moved up by a moderate rise of 7.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, P R Pharma Source had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹18,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2016 | Standard Chartered Bank | ₹3.00 M | Satisfied |
| 25 Mar 2015 | Standard Chartered Bank | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with P R Pharma Source, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of P R Pharma Source, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P R Pharma Source's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on P R Pharma Source Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity P R Pharma Source Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 22 Jun 2016 via Charge ID 100038667 with Standard Chartered Bank was fully satisfied on 19 Jul 2017. was completed.
Progress on A charge registered on 25 Mar 2015 via Charge ID 10560714 with Standard Chartered Bank was fully satisfied on 19 Jul 2017. was documented.
Progress on A charge with Standard Chartered Bank amounted to Rs. 3.00 M with Charge ID 100038667 was registered on 22 Jun 2016. was documented.
The activity A charge with Standard Chartered Bank amounted to Rs. 15.00 M with Charge ID 10560714 was registered on 25 Mar 2015. was completed.
The CIN of P R Pharma Source Private Limited is U52311MH2007PTC171721.
P R Pharma Source Private Limited is headquartered at A-407, Anjani Complex, Opp. Gurunanak Petrol Pump, Chakala, Andheri East,, Mumbai, Maharashtra, 400099.
P R Pharma Source Private Limited was incorporated on 16 June 2007.
The current directors of P R Pharma Source Private Limited are
The primary industry of P R Pharma Source Private Limited is Trade.
P R Pharma Source Private Limited is unlisted.
The authorized capital of P R Pharma Source Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of P R Pharma Source Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX